Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Br J Haematol. 2016 Mar 24;173(4):617–624. doi: 10.1111/bjh.14009

Table I.

Translational Research Topics of Likely Relevance for Future Patient Management

Molecular monitoring of
disease activity and
tumour burden		 Molecular diagnosis and
subtyping of NHL in
children		 Immunological therapy in
relation to paediatric NHL
biology
LBL moderate high low
BL/DLBCL moderate low high
ALCL high low high

LBL= lymphoblastic (precursor-cell) lymphoma, BL= Burkitt lymphoma, DLBCL= diffuse large B-cell lymphoma, ALCL= anaplastic large cell lymphoma; high= application in current or currently planned clinical trials, moderate= likely to be of relevance in future trials, low= clinical relevance in pediatric lymphoma currently not foreseen.